» Articles » PMID: 32363150

Induces Apoptosis in Gastric Cancer Cells Via Modulation of Signaling Pathways in

Overview
Journal Bioimpacts
Date 2020 May 5
PMID 32363150
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer is considered the second prevalent cause of death around the world. This type of cancer is generally induced by which could colonize within the gastric mucosa of the infected cases. To date, triple antibiotic therapy has routinely been utilized for controlling the induced infection. However, this strategy has been unsuccessful, in large part because of issues such as occurring point mutations in the genome that can induce resistance to the antibiotics administered. Recently, it has been shown that different probiotics may have strong anti-cancer effects, in which they are capable of inhibiting by both immunological and non-immunological mechanisms. Here, we aimed at finding possible anti-cancer impacts of the probiotic bacterium on gastric cancer, AGS cells. The anti-cancer effects of the conditioned media of the locally isolated on the AGS cells were evaluated by different analyses such as flow cytometry, DNA ladder assay, DAPI staining, and RT-PCR. Our findings showed that the conditioned media of can inhibit both and AGS cells through up-/down-regulation of PTEN, Bax, TLR4, and AKT genes. The exudates of the probiotic bacteria can increase the expression of PTEN, Bax, and TLR4, and also decrease the expression of AKT gene. In agreement with different reports, our results proved the anti-cancer effects of the locally isolated through some immunological cell signaling pathways. Accordingly, it seems the probiotics could be considered as at least a complementary treatment for different types of malignancies.

Citing Articles

Helicobacter pylori, microbiota and gastric cancer - principles of microorganism-driven carcinogenesis.

Wizenty J, Sigal M Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 40011753 DOI: 10.1038/s41575-025-01042-2.


Advances in 16S rRNA-Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis.

Wang Y, Qiu X, Chu A, Chen J, Wang L, Sun X Microb Biotechnol. 2025; 18(2):e70115.

PMID: 39992270 PMC: 11849407. DOI: 10.1111/1751-7915.70115.


The Influence of Gastric Microbiota and Probiotics in Infection and Associated Diseases.

Verma J, Anwar M, Linz B, Backert S, Pachathundikandi S Biomedicines. 2025; 13(1).

PMID: 39857645 PMC: 11761556. DOI: 10.3390/biomedicines13010061.


Effects of Lactobacillus spp. on Helicobacter pylori: A Promising Frontier in the Era of Antibiotic Resistance.

Dash D, Mishra V, Panda M, Pathak S Probiotics Antimicrob Proteins. 2024; .

PMID: 39499454 DOI: 10.1007/s12602-024-10396-z.


Antineoplastic with DNA fragmentation assay and anti-oxidant, anti-inflammatory with gene expression activity of Lactobacillus plantarum isolated from local Egyptian milk products.

Elhalik M, Mekky A, Khedr M, Suleiman W BMC Microbiol. 2024; 24(1):443.

PMID: 39472774 PMC: 11520475. DOI: 10.1186/s12866-024-03576-y.


References
1.
Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H . Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol. 2002; 32(2):105-10. DOI: 10.1111/j.1574-695X.2002.tb00541.x. View

2.
Dehghani J, Movafeghi A, Barzegari A, Barar J . Efficient and stable transformation of by 3 strains of . Bioimpacts. 2018; 7(4):247-254. PMC: 5801536. DOI: 10.15171/bi.2017.29. View

3.
Blosse A, Lehours P, Wilson K, Gobert A . Helicobacter: Inflammation, immunology, and vaccines. Helicobacter. 2018; 23 Suppl 1:e12517. PMC: 6310010. DOI: 10.1111/hel.12517. View

4.
Ma E, Choi Y, Choi J, Pothoulakis C, Rhee S, Im E . The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Int J Cancer. 2009; 127(4):780-90. PMC: 4420487. DOI: 10.1002/ijc.25011. View

5.
Yan F, Polk D . Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem. 2002; 277(52):50959-65. PMC: 4006994. DOI: 10.1074/jbc.M207050200. View